Pharmaceutical
Local 690, Hospital Reach Settlement on Outstanding Disputes
13:13 Feb 26, 2008
Genmab A/S announced today that the purchase agreement entered into between Genmab and PDL BioPharma, Inc. under which Genmab would acquire PDL's antibody manufacturing facility has received antitrust clearance from the US antitrust authorities under the
13:13 Feb 26, 2008
ARJO, Inc. announces the release of two new lifts, and a campaign including the Maxi Twin, a mobile lifter with a unique open, twin mast design, and the SARA Lite, a versatile standing and raising aid.
12:23 Feb 26, 2008
Dean Kilpatrick, Ph.D., MUSC distinguished university professor and director of the National Crime Victim's Research and Treatment Center at MUSC's Institute of Psychiatry, testified before Congress Feb 26 and will again on Feb. 27 on behalf of the PTSD
12:23 Feb 26, 2008
Athersys, Inc. today announced it will host a conference call on Wednesday, February 27, 2008 at 4:15 PM to review the top-line data results of the Phase I clinical trial of ATHX-105, its leading drug development candidate for the treatment of obesity.
12:13 Feb 26, 2008
Ortho Biotech believes that the conclusions of a study published in the February 27, 2008 issue of the Journal of the American Medical Association by Bennett, et al, do not provide an accurate reflection of the safety profile of erythropoiesis-stimulatin
11:53 Feb 26, 2008
Masimo Corporation , the inventor of Pulse CO-Oximetry and Measure-Through Motion & Low Perfusion pulse oximetry, today announced its financial results for both the quarter and year ended December 29, 2007.
11:53 Feb 26, 2008
MONTREAL, Feb. 26 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. announced today that it has signed the definitive agreement for development of two hyperimmunes with Kedrion S.p.A. .
11:53 Feb 26, 2008
Citing a Center for Medicare and Medicaid Services report released today projecting that Medicare will consume over 20 percent of national health care spending by 2017, House Republican Roy Blunt issued the following statement urging the House to take up
11:53 Feb 26, 2008
SyntheMed, Inc. , a biomaterials company engaged in the development and commercialization of anti-adhesion products, drug delivery products and other surgical implants, announced today that Robert P. Hickey, President and CEO, will present at the Canacco
11:43 Feb 26, 2008
Family and Physicians Offer Statements Regarding her Care and Recovery
11:43 Feb 26, 2008
ProMetic Sciences de la Vie inc. annonce aujourd'hui qu'elle a conclu une entente de licence définitive avec Kedrion S.p.A. visant le développement de deux hyperimmuns.
11:34 Feb 26, 2008
ProMetic Life Sciences Inc. announced today that it has signed the definitive agreement for development of two hyperimmunes with Kedrion S.p.A. .
11:34 Feb 26, 2008
ViroPharma Incorporated announced today that, effective March 31, 2008, Vincent J. Milano will succeed Michel de Rosen as president and chief executive officer of the company and has been elected to its board of directors. Mr. de Rosen, who has led the c
11:33 Feb 26, 2008
Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview at the upcoming SIGnificant Investment Options in Healthcare Conference hosted by Susquehanna Financial Group on Wednesday, March 5, 2008 at 4:00 p.m. E
11:33 Feb 26, 2008
57925 - 57939 of 73669 Stories
<<
<
Next 15 Pharmaceutical
>
>>
Search News
Daily News
